Variable (units) pGDM-P n=29 pGDM-N n=56 pNGT N=40 p-values
Age (years) 31.50 (27.50 - 35.50) 30.00 (26.00 - 35.00) 27.00 (25.00 - 35.50) 0.1145
BMI (kg/m2) 25.12 (21.83 - 29.04)b 24.44 (21.26 - 27.22)a 22.00 (20.31 - 24.33) 0.0022
Waist circumference (cm) 80.00 (73.00 - 96.00)b 82.00 (73.00 - 90.00)a 74.50 (69.00 -78.00) 0.0010
Fasting plasma glucose(mmol/l) 5.16 (4.77 - 5.88)b,c 4.77 (4.44 - 5.13) 4.72 (4.50 - 4.78) 0.0002
2-h (OGTT) plasma glucose (mmol/l) 8.27 (8.05 - 8.77)b,c 5.88 (5.44 - 6.66)a 4.84 (4.77 - 5.44) <0.0001
Insulin (pmol/l) 57.44 (42.36 - 95.84)cc 54.17 (41.67 - 69.45) 63.20 (54.87 - 71.53) 0.0353
sVCAM-1 (ng/ml) 960.30 (353.73 - 1638.03) 1127.63 (466.68 - 1582.58)a 672.05 (455.70 - 1113.46) 0.0553
sICAM-1 (ng/ml) 295.90 (238.80 - 363.38)b 299.28 (243.46 - 364.19)a 140.40 (121.34 - 179.90) <0.0001
sE-selectin (ng/ml) 35.80 (26.37 - 43.65)b 28.57 (20.35 - 42.54)a 20.90 (17.11 - 26.01) 0.0022
tPA:Ag (ng/ml) 6.01 (4.09 - 7.51)b 4.68 (3.25 - 7.24)a 3.50 (2.66 - 4.64) 0.0005
vWF:Ag (%) 107.79 (96.20 - 131.59) 104.30 (95.36 - 117.22) 104.87 (74.96 - 125.67) 0.6498
PAI-1:Ag (ng/ml) 57.67 (49.44 - 83.75) 57.09 (42.85 - 85.12) 71.36 (50.54 - 81.80) 0.2178
hsCRP (µg/ml) 1.30 (0.81 - 2.86)b 1.32 (0.66 - 2.76)a 0.41 (0.22 - 0.79) <0.0001
Total-cholesterol (mmol/l) 5.33 (4.84 - 5.92)b 5.02 (4.50 - 5.48)a 4.56 (4.27 - 5.09) 0.0022
HDL- cholesterol (mmol/l) 1.45 (1.29 - 1.73)b 1.55 (1.27 - 1.73)a 1.73 (1.56 - 1.82) 0.0048
LDL- cholesterol (mmol/l) 3.26 (2.97 - 4.06)b 3.03 (2.77 - 3.54)a 2.57 (2.30 - 3.05) <0.0001
Triglyceride (mmol/l) 1.21 (1.02 - 2.22)b,c 79.00 (63.00 - 116.00) 74.50 (58.50 - 91.00) 0.0004
Triglyceride/ HDL cholesterol 1.83 (1.35 - 4.06)b,c 1.33 (0.95 - 2.30) 1.11 (0.89 - 1.50) 0.0003
HOMA-IR (mmol/l) 2.32 (1.27 - 3.49)ccc 1.64 (1.22 - 2.15) 1.89 (1.58 - 2.37) 0.0499
P-values for testing over the three groups (ANOVA): a-p<0.05 controls versus previous GDM with normal glucose regulation; b-p<0.05 controls versus previous GDM with pre-diabetic state; c-p<0.05 previous GDM with normal glucose status versus previous GDM with prediabetic state, cc-p=0,05, ccc-p=0,06
Table 2: Clinical and laboratory data for participants in studied groups: pGDM-P, pGDM-N and pNGT as a control group.